Why PLM is Critical for Pharma’s Digital Transformation

Pharmaceutical development involves multiple stages: research, preclinical studies, clinical trials, manufacturing, regulatory approvals, market launch, and post‑market surveillance. Each stage generates large volumes of data  protocols, test results, formulation details, batch records, packaging specifications, regulatory documentation. Managing this complexity using spreadsheets or siloed systems is risky and inefficient.

As regulators demand stricter documentation, traceability and compliance, pharma companies increasingly need a unified, robust framework to manage every step in the drug lifecycle. That framework is provided by Product Lifecycle Management (PLM).

What is PLM ?

Product Lifecycle Management (PLM) refers to systems and practices that manage a product’s journey from conception through development, manufacturing, launch, maintenance and eventual retirement. In manufacturing industries, PLM has long been used to manage design, engineering, components, and end‑to‑end workflows. 

In pharma, PLM adapts these capabilities to drug products  managing data across R&D, clinical development, regulatory filings, manufacturing, packaging and beyond. 

Rather than operating in departmental silos, PLM provides a unified “single source of truth” for product data  formulations, process definitions, manufacturing recipes, quality control parameters, regulatory documentation, and change history. 

This lifecycle‑wide visibility and control is essential for complex, regulated products like pharmaceuticals.

How PLM Supports the Full Drug Lifecycle (Discovery → Distribution)

Here is how PLM can map to the various phases of a drug’s lifecycle:

• Discovery & Research: Capture initial formulations, active‑ingredient candidates, preclinical data  creating structured records from the outset.
• Preclinical & Clinical Development: Store documented protocols, batch formulations, trial data, CMC (chemistry, manufacturing, controls) data  ensuring traceability and version control.
• Tech Transfer & Manufacturing Scale-up: Use PLM to manage manufacturing recipes, regulatory documentation, site-specific variations, packaging components  especially valuable when scaling from lab to manufacturing environment.
• Regulatory Submission & Approval: Leverage structured, validated documentation for submissions, with full traceability of changes, batches, formulations  reducing risk of submission delays or rejections.
• Market Launch and Lifecycle Management: Manage packaging, supply‑chain, manufacturing changes, post‑market surveillance data, version control for product variations (e.g. generics, reformulations, line extensions).

By providing centralized data governance and process traceability, PLM ensures every stakeholder  R&D, quality, manufacturing, regulatory, supply‑chain  works from the same updated product record.

Key Benefits: Traceability, Compliance, Speed, Quality

Implementing PLM in pharma delivers multiple strategic benefits:

• Full Traceability & Data Integrity: Every change  formulation, batch recipe, process parameter  is logged, versioned, and traceable. This helps meet regulatory expectations and ensures consistent quality across batches.
• Regulatory Compliance & Risk Mitigation: With robust documentation, audit trails, and change‑control workflows, companies reduce the risk of compliance failures, regulatory rejections or recalls.
• Faster Time-to-Market: PLM breaks down silos, speeds up collaboration between departments (R&D, manufacturing, regulatory), and reduces delays caused by miscommunication or data ambiguity.
• Standardization and Quality Control: PLM enforces standardized processes, recipes, documentation and product definitions  reducing variability and improving reliability across production sites.
• Better Collaboration & Cross‑Functional Workflows: By creating a common digital backbone, teams across functions and geographies can access the same up‑to‑date product data, improving coordination and reducing errors.
• Lifecycle Cost Reduction & Process Efficiency: PLM helps manage product changes, formulations, line extensions or dosage variations more efficiently  lowering overheads and improving scalability.

Given increasing regulatory scrutiny, rising costs, and demand for faster delivery, PLM is becoming indispensable for pharma digital transformation.

How Low‑Code Tools Complement PLM for Better Adoption

PLM adoption in pharma is often hampered by legacy systems, manual processes, and resistance to change. This is where low-code platforms come into play.

Low-code tools enable rapid creation of user-friendly interfaces and workflows that sit on top of PLM back‑ends  making it easier for scientists, quality managers, regulatory teams, and supply‑chain staff to interact with PLM data without deep software knowledge. This democratizes access to the PLM system and accelerates adoption.

By using low-code to build custom dashboards, approval flows, document submission modules, batch‑release workflows, and data entry forms, organizations can integrate PLM deeply into everyday operations  eliminating paperwork, reducing manual errors, and ensuring compliance.

Low‑code + PLM also supports agility: changes to formulations, regulatory requirements, or manufacturing protocols can be updated quickly, with full version control and traceability, and immediately reflected across all modules.

This combination helps pharma companies get the benefits of PLM without the heavy cost and delay typically associated with custom enterprise software.

Case Study Scenario:

Scenario: A mid‑size pharmaceutical company developing a novel drug faces delays  trial data scattered across spreadsheets, formulation recipes in separate documents, batch records managed manually, and approval workflows assigned via email. Multiple handoffs lead to errors, lost data, and regulatory audit risks.

Solution: The company implements a PLM system as the core repository for all product data  formulations, batch records, clinical trial data, packaging specifications, regulatory documents. On top of this, a low‑code platform is used to build tailored workflows  data capture forms for trials, batch‑release approval flows, packaging checklist modules, and dashboards for quality and regulatory teams.

Execution:

• R&D, clinical, manufacturing and regulatory teams migrate existing data into structured PLM records.
• Low‑code apps are built to handle trial data entry, batch documentation, QC approvals, and packaging instructions.
• Change‑control workflows are defined: any change in formulation or manufacturing recipe triggers approval workflows, update logs, and documentation audits.
• Dashboards provide visibility across departments  e.g. trial progress, quality deviations, batch release status, regulatory submission readiness.

Results:

• Data inconsistency and manual hand‑offs disappear. All teams access the same, validated product truth.
• Batch release cycles accelerate by 30‑40 percent due to streamlined approvals and fewer errors.
• Regulatory submission readiness improves  all documentation and history are traceable and audit‑ready.
• Collaboration across departments improved significantly  faster decisions, clearer accountability, fewer data silos.

This case demonstrates how PLM, when complemented by low‑code tools, drives operational excellence, reduces risk, and accelerates time‑to‑market.

Challenges & Considerations

Adopting PLM and integrating it with low‑code must be planned carefully to realize full benefits:

• Data Migration and Governance: Legacy data may be inconsistent or siloed. Migration requires cleanup, standardization, and mapping. Governance models must be defined early.
• Change Management: Teams may resist change  need training, buy‑in, and clarity on workflows and responsibilities.
• Regulatory Validation & Compliance: Systems must meet regulatory standards (e.g. FDA, EMA, ICH). PLM implementations must be validated; documentation and audit trails must be robust.
• Integration Complexity: PLM must integrate with lab systems, manufacturing execution systems (MES), quality management systems (QMS), ERP, supply‑chain management. Proper planning and architecture are essential.
• Scalability and Maintenance: As products evolve (new formulations, variants, generics, line extensions), PLM must scale  with version control, global collaboration and support for multiple markets.

When done right, these challenges become strengths  delivering long term value and agility.

Why 9NEXUS Is a Good Partner for PLM‑Driven Transformation

At 9NEXUS, we combine domain understanding of pharma with technical expertise in PLM and low‑code solutions. Our capabilities include:

• Setting up PLM frameworks suited to drug lifecycle  data models, product records, change management and compliance workflows.
• Building low‑code front‑ends and workflow modules aligned to pharma operations  lab data capture, batch release, packaging, regulatory submissions.
• Integrating PLM with existing systems (MES, QMS, ERP, lab systems) to ensure a unified information backbone.
• Implementing validation, audit‑trail, and documentation protocols to meet regulatory standards.
• Training and onboarding of cross-functional teams  R&D, manufacturing, quality, regulatory  to adopt PLM and low‑code workflows.

This ensures your transformation is not just technical but organizational  enabling real, operational change.

Conclusion

For pharmaceutical companies navigating the complexity of drug development, manufacturing, regulatory compliance and market dynamics, PLM is no longer optional  it’s critical.

By providing a unified, traceable, version-controlled backbone for the drug lifecycle  from discovery to distribution  PLM ensures consistency, compliance, quality, and scalability. When combined with low‑code tools, PLM becomes accessible, agile and deeply embedded in day‑to‑day operations.

This combination reduces risk, accelerates time-to-market, improves collaboration and ultimately supports delivering safe, effective therapies to patients faster.

Implementing PLM with a trusted partner such as 9NEXUS helps pharma companies unlock the full potential of enterprise‑wide digital transformation.